AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2.
Chibwana MG, Moyo-Gwete T, Kwatra G, Mandolo J, Hermanaus T, Motlou T, Mzindle N, Ayres F, Chaponda M, Tembo G, Mwenechanya P, Mitole N, Jassi C, Kamng'ona R, Afran L, Mzinza D, Mwandumba HC, Gordon SB, Jere K, Madhi S, Moore PL, Heyderman RS, Jambo KC.
Chibwana MG, et al. Among authors: madhi s.
BMC Med. 2022 Mar 28;20(1):128. doi: 10.1186/s12916-022-02342-z.
BMC Med. 2022.
PMID: 35346184
Free PMC article.